Square Four Projects India Ltd
Incorporated in 1992, Square Four Projects India Ltd is in the development of infrastructure and real estate[1]
- Market Cap ₹ 18.6 Cr.
- Current Price ₹ 9.49
- High / Low ₹ 13.1 / 7.35
- Stock P/E
- Book Value ₹ 9.96
- Dividend Yield 0.00 %
- ROCE -0.04 %
- ROE -0.41 %
- Face Value ₹ 5.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.95 times its book value
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -0.58% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
0.18 | 0.19 | 0.20 | 0.26 | 0.23 | 1.85 | 0.19 | 0.21 | 0.27 | 0.25 | 0.25 | |
Operating Profit | -0.18 | -0.19 | -0.20 | -0.26 | -0.23 | -1.85 | -0.19 | -0.21 | -0.27 | -0.25 | -0.25 |
OPM % | |||||||||||
0.20 | 0.21 | 0.22 | 0.08 | 0.13 | 2.42 | 0.13 | 0.12 | 0.11 | 0.24 | 0.21 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | 0.02 | 0.02 | 0.02 | -0.18 | -0.10 | 0.57 | -0.06 | -0.09 | -0.16 | -0.01 | -0.04 |
Tax % | 0.00% | 0.00% | 50.00% | 0.00% | 10.00% | 0.00% | 16.67% | 11.11% | 0.00% | 700.00% | |
0.02 | 0.02 | 0.01 | -0.18 | -0.12 | 0.57 | -0.08 | -0.10 | -0.16 | -0.08 | -0.04 | |
EPS in Rs | 0.01 | 0.01 | 0.01 | -0.09 | -0.06 | 0.29 | -0.04 | -0.05 | -0.08 | -0.04 | -0.03 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 6% |
3 Years: | 0% |
TTM: | 64% |
Stock Price CAGR | |
---|---|
10 Years: | -12% |
5 Years: | 1% |
3 Years: | 2% |
1 Year: | -23% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -2% |
3 Years: | -1% |
Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9.81 | 9.81 | 9.81 | 9.81 | 9.81 | 9.81 | 9.81 | 9.81 | 9.81 | 9.81 |
Reserves | 26.18 | 9.90 | 9.91 | 9.72 | 9.61 | 10.15 | 10.08 | 9.97 | 9.81 | 9.73 |
2.19 | 3.58 | 3.68 | 3.85 | 4.02 | 3.72 | 3.79 | 3.79 | 4.07 | 1.27 | |
3.29 | 0.27 | 0.34 | 0.33 | 0.29 | 0.08 | 0.08 | 0.10 | 0.05 | 0.11 | |
Total Liabilities | 41.47 | 23.56 | 23.74 | 23.71 | 23.73 | 23.76 | 23.76 | 23.67 | 23.74 | 20.92 |
35.38 | 16.21 | 16.21 | 16.21 | 16.21 | 15.90 | 15.90 | 15.90 | 15.90 | 15.90 | |
CWIP | 1.93 | 1.40 | 1.56 | 1.56 | 1.60 | 1.65 | 1.70 | 1.75 | 1.93 | 2.13 |
Investments | 0.13 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 |
4.03 | 5.55 | 5.57 | 5.54 | 5.52 | 5.81 | 5.76 | 5.62 | 5.51 | 2.49 | |
Total Assets | 41.47 | 23.56 | 23.74 | 23.71 | 23.73 | 23.76 | 23.76 | 23.67 | 23.74 | 20.92 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
2.85 | 0.18 | 0.04 | -0.15 | -0.27 | -2.32 | -0.13 | -0.07 | 1.66 | 0.89 | |
-1.48 | -0.16 | -0.16 | 0.00 | 0.10 | 2.67 | 0.08 | 0.06 | -0.07 | 0.04 | |
-0.97 | 0.00 | 0.10 | 0.17 | 0.18 | -0.34 | 0.07 | 0.00 | 0.28 | -2.80 | |
Net Cash Flow | 0.40 | 0.03 | -0.02 | 0.02 | 0.01 | 0.01 | 0.02 | -0.01 | 1.87 | -1.87 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | ||||||||||
Inventory Days | ||||||||||
Days Payable | ||||||||||
Cash Conversion Cycle | ||||||||||
Working Capital Days | ||||||||||
ROCE % | 0.06% | 0.09% | -0.47% | -0.43% | -7.30% | -0.25% | -0.38% | -0.68% | -0.04% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 2d
-
Intimating The Shareholders The Weblink Of The Annual Report For The Financial Year 2024-2025
30 Aug - AGM on September 24, 2025 via VC; annual report weblink sent to physical shareholders.
- Reg. 34 (1) Annual Report. 29 Aug
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
27 Aug - AGM Notice - Pre Dispatch Newspaper Publication
-
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
18 Aug - Appointment of P A R V Associates as statutory auditors for five years from FY 2025-26 to FY 2029-30.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2010
from bse
Operational Status:[1][2]
The company, formerly known as Essen Supplements India Ltd, operates in real estate activities but has not generated revenue for many years, leading to recurring losses. The management is actively exploring better business opportunities to improve the company's prospects.